
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1023 | 998 | 1151 | 1311 | 1745 | 2110 |
Fund Return | 2.25% | -0.23% | 15.11% | 9.45% | 11.77% | 7.75% |
Place in category | - | - | - | - | - | - |
% in Category | - | - | - | - | - | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
AGF Global Select Series F CAD | 5.39B | 4.81 | 15.83 | 16.40 | ||
AGF American Growth Class Series T | 3.65B | 0.91 | 16.07 | 14.33 | ||
AGF American Growth Class CAD | 3.65B | 1.57 | 16.27 | 14.32 | ||
AGF Global Dividend Fund CAD | 2.49B | 5.53 | 12.40 | 7.58 | ||
AGF Global Dividend Fund Series CAD | 2.49B | 5.74 | 13.72 | 8.83 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Fidelity Canadian Growth Comp Sr A | 12.22B | 1.50 | 15.48 | 12.50 | ||
Fidelity Canadian Growth Comp Sr F | 12.22B | 1.73 | 17.07 | 14.04 | ||
Fidelity Canadian Growth Comp Sr B | 12.22B | 1.54 | 15.74 | 12.74 | ||
Fidelity Canadian Large Cap Sr F | 9.07B | 4.71 | 12.85 | 9.76 | ||
Fidelity Canadian Large Cap Sr F5 | 9.07B | 4.30 | 12.71 | 9.73 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Canadian Natural | CA1363851017 | 5.17 | 41.39 | -1.50% | |
Microsoft | US5949181045 | 4.64 | 378.77 | -1.17% | |
Toronto Dominion Bank | CA8911605092 | 4.39 | 83.27 | -0.76% | |
UnitedHealth | US91324P1021 | 4.00 | 481.52 | +0.09% | |
RBC | CA7800871021 | 3.56 | 108.81 | -2.22% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Strong Sell | Strong Sell | Sell |
Technical Indicators | Strong Sell | Strong Sell | BUY |
Summary | Strong Sell | Strong Sell | Neutral |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review